-
Featured News
Novartis announces discontinuation of CIRRUS-1 study of CFZ533 (iscalimab) in kidney transplant patients
-
Featured News
Novartis receives FDA fast track designation for LNA043 in osteoarthritis of the knee
-
Featured News
Novartis sabatolimab receives orphan drug designation from the European Commission for myelodysplastic syndromes
-
Featured News
FDA accelerates review of Novartis STAMP inhibitor asciminib (ABL001) for patients with chronic myeloid leukemia (CML)
-
Media Library
What do you know about noncommunicable diseases?
-
Media Library
The Museum of MS
-
Media Library
Novartis and the International Red Cross partner to provide medicines to Syrian refugees
-
Media Library
Novartis Access: How We'll Expand Access to Healthcare
-
Media Library
Experts gather to explore response to chronic illness in poor countries
-
Media Library
ALK+ Non-Small Cell Lung Cancer Patient Video: Miriam & Joel
-
Media Library
ALK+ Non-Small Cell Lung Cancer Patient Video: Anne Marie
-
Media Library
Acute Myeloid Leukemia: Unique Needs for Patients and Caregivers